Get the Stockscreener App
92.58
0.90%
0.83
Boston Scientific Corp stock is traded at $92.58, with a volume of 7.73M.
It is up +0.90% in the last 24 hours and down -11.09% over the past month.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
See More
Previous Close:
$91.75
Open:
$92.21
24h Volume:
7.73M
Relative Volume:
0.79
Market Cap:
$137.24B
Revenue:
$19.35B
Net Income/Loss:
$2.78B
P/E Ratio:
49.52
EPS:
1.8696
Net Cash Flow:
$3.82B
1W Performance:
-5.07%
1M Performance:
-11.09%
6M Performance:
-6.07%
1Y Performance:
+2.39%
1-Day Range:
$91.53
$93.38
1-Week Range:
$91.45
$97.07
52-Week Range:
$85.98
$109.50
Boston Scientific Corp Stock (BSX) Company Profile
Name
Boston Scientific Corp
Sector
Industry
Phone
508-683-4000
Address
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
92.58 | 136.01B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
ABT
Abbott Laboratories
|
125.46 | 214.37B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
354.09 | 134.98B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.87 | 127.88B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.08 | 48.88B | 5.88B | 1.34B | 799.60M | 2.3489 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-03-25 | Downgrade | Erste Group | Buy → Hold |
| Sep-08-25 | Upgrade | Oppenheimer | Perform → Outperform |
| Jun-16-25 | Initiated | Leerink Partners | Outperform |
| Apr-16-25 | Upgrade | Needham | Hold → Buy |
| Jan-10-25 | Upgrade | Deutsche Bank | Hold → Buy |
| Oct-18-24 | Downgrade | Needham | Buy → Hold |
| May-30-24 | Initiated | Goldman | Buy |
| Feb-01-24 | Upgrade | Mizuho | Neutral → Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Jun-30-23 | Initiated | CL King | Buy |
| May-30-23 | Resumed | Morgan Stanley | Overweight |
| Mar-29-23 | Initiated | UBS | Buy |
| Dec-22-22 | Initiated | Mizuho | Neutral |
| Dec-20-22 | Resumed | Citigroup | Buy |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-06-22 | Initiated | Wolfe Research | Outperform |
| May-27-22 | Upgrade | Needham | Hold → Buy |
| Apr-13-22 | Resumed | Truist | Buy |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| May-26-21 | Downgrade | Needham | Buy → Hold |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-15-21 | Initiated | Atlantic Equities | Overweight |
| Sep-17-20 | Initiated | Truist | Buy |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| Apr-22-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-01-20 | Upgrade | Goldman | Neutral → Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Neutral |
| Feb-06-20 | Resumed | BTIG Research | Buy |
| Dec-30-19 | Reiterated | Cowen | Outperform |
| Dec-19-19 | Downgrade | Needham | Strong Buy → Buy |
| Sep-05-19 | Resumed | JP Morgan | Overweight |
| Sep-03-19 | Resumed | Barclays | Overweight |
| May-13-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Nov-28-18 | Initiated | UBS | Buy |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Oct-02-18 | Reiterated | Morgan Stanley | Overweight |
| Sep-07-18 | Reiterated | Needham | Strong Buy |
| Sep-04-18 | Upgrade | Jefferies | Hold → Buy |
| Jul-06-18 | Reiterated | Needham | Strong Buy |
| Jun-27-18 | Initiated | Bernstein | Outperform |
| Apr-26-18 | Reiterated | Needham | Strong Buy |
View All
Boston Scientific Corp Stock (BSX) Latest News
National Bank of Canada FI Has $150.83 Million Holdings in Boston Scientific Corporation $BSX - MarketBeat
Treasurer of the State of North Carolina Has $74.06 Million Position in Boston Scientific Corporation $BSX - MarketBeat
Gilder Gagnon Howe & Co. LLC Has $120.86 Million Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
Engineers Gate Manager LP Sells 29,586 Shares of Boston Scientific Corporation $BSX - MarketBeat
Adage Capital Partners GP L.L.C. Has $220.77 Million Holdings in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation (BSX) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade
The Beat: Boston Scientific, Daikin Applied invest big on real estate, Saluda Medica raises $150M IPO - The Business Journals
Quantinno Capital Management LP Has $36.94 Million Stake in Boston Scientific Corporation $BSX - MarketBeat
Analysts Are Bullish on Top Healthcare Stocks: Azenta (AZTA), Boston Scientific (BSX) - The Globe and Mail
Boston Scientific Corporation $BSX Shares Sold by DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main - MarketBeat
Boston Scientific Corporation $BSX Shares Bought by Armistice Capital LLC - MarketBeat
Boston Scientific (BSX) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance
TD Cowen reaffirms Boston Scientific stock rating with $115 price target - Investing.com
Boston Scientific Sustains Momentum in the PFA Market: What's Next? - Nasdaq
New insurance policy benefits Boston Scientific Intracept procedure - MassDevice
Boston Scientific Stock Is Dropping: Reasons Behind BSX Sell-Off - EBC Financial Group
Boston Scientific (BSX) Extends Losing Streak: What Tuesday’s Close Means Before the Bell on December 10, 2025 - ts2.tech
A Look Into Boston Scientific Inc's Price Over Earnings - Benzinga
Boston Scientific buys new Minnesota facility for nearly $189M - MassDevice
Boston Scientific Corporation $BSX Shares Purchased by State Street Corp - MarketBeat
Boston Scientific buys major Minneapolis-area property for $188M - NBC Boston
Boston Scientific pays $188 million for newly built Minn. facility - The Business Journals
Boston Scientific (BSX): Evaluating Valuation After Fresh Evidence of Sustained Growth in Minimally Invasive Devices - Yahoo Finance
Is Boston Scientific’s (BSX) Aggressive R&D Push Quietly Redefining Its Long‑Term Growth Story? - Yahoo Finance
Boston Scientific pays $188 million for newly built Maple Grove facility - The Business Journals
California Public Employees Retirement System Reduces Stake in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX is Bollard Group LLC's Largest Position - MarketBeat
Boston Scientific Corporation $BSX Shares Bought by Baird Financial Group Inc. - MarketBeat
Boston Scientific Corporation (BSX): A Bull Case Theory - Finviz
Boston Sci brings next-generation Rezūm EVO Console to the UK - BioWorld MedTech
Boston Scientific pays high price for new Maple Grove facility - Finance & Commerce
Has Boston Scientific’s Strong Runway in Minimally Invasive Therapies Stretched Its Valuation? - Yahoo Finance
Boston Scientific gets European nod for Farapoint catheter - MassDevice
Sinuscope Market Forecast Report 2032 | Olympus Corporation, - openPR.com
What valuation ratios show for Boston Scientific Corporation stockWatch List & High Accuracy Swing Entry Alerts - Newser
Why Boston Scientific Corporation stock remains on buy lists2025 Technical Overview & Stepwise Trade Execution Plans - Newser
Boston Scientific Corporation (NYSE:BSX) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Boston Scientific Stock (BSX) on December 3, 2025: Insider Sales, EU Device Win and Strong 2026 Price Targets - ts2.tech
Boston Scientific put volume heavy and directionally bearish - TipRanks
Quantbot Technologies LP Grows Holdings in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Insiders Sell US$2.4m Of Stock, Possibly Signalling Caution - Yahoo Finance
Groupe la Francaise Purchases 297,049 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Executive Sells Over $1.7 Million in Company Stock - TradingView
Boston Scientific executive exercises options, sells 17,313 shares | BSX SEC FilingForm 4 - Stock Titan
M&A Strategy Strengthens Boston Scientific's Growth Prospects - Nasdaq
Fisher Asset Management LLC Acquires 939,834 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Shares Sold by Arrowstreet Capital Limited Partnership - MarketBeat
Boston Sci's Farapoint secures CE mark - BioWorld MedTech
[Form 4] BOSTON SCIENTIFIC CORP Insider Trading Activity - Stock Titan
[144] BOSTON SCIENTIFIC CORP SEC Filing - Stock Titan
This investor loves Boston Scientific - Cantech Letter
Boston Scientific Corp Stock (BSX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.32%
1.38%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):